Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Dicerna enrolling in phase II study of DCR-PHXC for primary hyperoxaluria

March 11, 2019

Eli Lilly and Company synthesizes PDE1 inhibitors

March 4, 2019

Lilly synthesizes new phosphodiesterase PDE1 inhibitors

Feb. 26, 2019

Imarikiren improves albuminuria in patients with type 2 diabetes

Feb. 22, 2019

DDR1 inhibitor seen to prevent renal function loss in mice

Feb. 21, 2019

Positive data presented from phase II PHOENIX study of bardoxolone methyl

Feb. 21, 2019

Dual complement inhibition by CRIg/FH shows renoprotective effect in ischemia reperfusion injury

Feb. 18, 2019

New phase III study of empagliflozin assesses cardio-renal outcomes in chronic kidney disease

Feb. 8, 2019

First mouse kidneys grown from mouse stem cells in rats

Feb. 8, 2019

Nash Pharmaceuticals reports preclinical activity and new compounds for kidney disease

Jan. 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...